organ-confined disease

organ-confined disease

An illness, such as a tumor or an abscess, that has not spread beyond the organ in which it originated. One example is prostate cancer that is confined within the prostate gland and has not entered the seminal vesicles or pelvic lymph nodes.
References in periodicals archive ?
adrenal-sparing), which was expected given the excellent prognosis with pT1a tumours, as was the case in our series with organ-confined disease.
9,10) PSA testing had a significant impact in diagnosing early, organ-confined disease (11) despite low sensitivity and specificity.
3) Also in our opinion, patients with truly clinically organ-confined disease may be reserved for adjuvant chemotherapy (AC); because at least in theoretical basis AC should be equally effective as NAC in this group of patients.
The results support findings from a previous longitudinal, population-based study of nearly 29,000 men that suggested obesity may protect against development of organ-confined disease.
0765 could distinguish patients with extracapsular extension (ECE) from those with organ-confined disease (OCD), with a sensitivity of 100% and a specificity of 93%.
Six months post-treatment, organ-confined disease, 40-50 years) This sort of macho thing.
In patients with organ-confined disease (pT1a-pT2b), PSA and hK2 were detected in 6 of 10 patients, whereas 3 patients were negative for both PSA and hK2 mRNA.
Radiotherapy has had varying rates of success when used in the adjuvant setting, and hormone deprivation therapy cannot preoperatively downstage a prostate cancer to improve rates of organ-confined disease.
2) Of those with organ-confined disease who undergo nephrectomy, 20% will relapse with recurrent RCC.
Treatment decisions for men with localized prostate cancer could be improved with more accurate knowledge at the time of diagnosis for the individual patient, including likelihood of favorable features such as low grade, organ-confined disease or low probability of tumor recurrence," said Eric Klein, M.
The nine-year results using TheraSeed(R) in this series add to the growing body of knowledge that brachytherapy can achieve a high rate of success for patients with organ-confined disease.